Form 4: ESSA Pharma COO Peter Virsik Sells Shares Under 10b5-1 Trading Plan

Peter Virsik, Chief Operating Officer of ESSA Pharma Inc., sold 694 common shares at an average price of $8.98 on March 5, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• On March 5, 2024, Peter Virsik, the Chief Operating Officer of ESSA Pharma Inc., sold 694 common shares of the company.
• The sale was executed at a weighted average price of $8.98 per share.
• This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan that Mr. Virsik entered into on August 31, 2023.
• Following the transaction, Mr. Virsik directly owns 12,634 common shares of ESSA Pharma Inc.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine sale under a pre-arranged trading plan and doesn't necessarily indicate a positive or negative outlook for the company.

Industry Context

Sales by company insiders are a common occurrence and are often viewed in the context of pre-arranged trading plans to avoid accusations of trading on inside information. The market typically assesses the volume and frequency of such sales to gauge potential impact.

Stakeholder Impact

• The sale of shares by a company officer could have a minor impact on shareholder sentiment, depending on the size and frequency of such transactions.

Key Dates